朱慧丽

2005年硕士毕业于中山大学，2005年至今在暨南大学附属第一医院工作。

擅长脑血管疾病、神经危重症、头晕头痛等疾病的诊治。

1.Huili Zhu, Yusheng Zhang, Zhongshan Shi, Dan Lu, Tingting Li, Yan Ding, Yiwen Ruan*, Anding Xu*. The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways. Scientific Reports, 2016,31;6:26859.2.2.Bing Yang#, Huili Zhu#, Yusheng Zhang and Anding Xu. High-Resolution Magnetic Resonance Imaging Confirmed Atherosclerosis of an Intracranial Penetrating Artery: A Case Report. J Stroke Cerebrovasc Dis. 2018,(18):30061-2. 3.3.Hui-li Zhu, Si-Ming Xie, Mao Fang, Ji-Jun Zhang, Ze-Ping Weng and Xue-Yun Zhong*. 4E-BP1 regulates the sensitivity of human glioma cells to chemotherapy through PI3K/Akt/mTOR-independent pathway. Neuropathology, 2014, 34(3):227-35.4.Lizhen He, Yanyu Huang, Huili Zhu, Guanhua Pang, Wenjie Zheng, Yum-Shing Wong, and Tianfeng Chen*. Cancer-targeted Monodisperse Mesoporous Silica Nanoparticles as Carrier of Ruthenium Polypyridyl Complexes to Enhance Theranostic Effects. Advanced Functional Materials, 2014, 24(19):2737-47.2.5.朱慧丽，翁泽平，林琛莅，马继伟，钟雪云*. GLP-1通过下调ATGL表达参与3T3-L1脂肪细胞脂质代谢，南方医科大学学报，2013,33(10):1499-503.3.6.朱慧丽，翁泽平，张继君，林琛莅，谢思明，王 超，马继伟，钟雪云*.4E-BP1在人脑胶质瘤细胞对卡氮芥获得性耐药中的作用. 中国病理生理杂志，2013,29(7):1192-1196.7.HualianWu, HuiliZhu, XiaolingLi, ZumeiLiu, WenjieZheng*, TianfengChen, BoYu, andKa-HingWong*. Induction of Apoptosis and Cell Cycle Arrest in A549 Human Lung Adenocarcinoma Cells by Surface-Capping Selenium Nanoparticles: An Effect Enhanced by Polysaccharide-Protein Complexes from Polyporus rhinoceros. Journal of Agricultural and food Chemistry, 61(41):9859-66, 2013.

中国卒中学会重症脑血管病分会青年委员

广东省医学会神经病学分会危急重症学组成员

广东省中西医结合学会卒中专业委员会委员

中国卒中学会成员

擅长脑血管疾病、神经危重症、头晕头痛等疾病的诊治。

脑血管疾病，特别是合并糖尿病的缺血性脑卒中的基础和临床研究。获得广东省自然科学基金、广州市科技计划项目等多个科研基金。